If you have room for a share or two in your portfolio then take a look at the excellent ASX 200 shares listed below.
Analysts have recently tipped these shares as ones to buy. Here’s what you need to know:
CSL Limited (ASX: CSL)
The first ASX 200 share for investors to look at is CSL. It is one of the world’s leading biotechnology companies and the name behind the CSL Behring and Seqirus businesses. Both are leaders in their respective fields of plasma therapies and vaccines.
In addition, the company is in the process of making a major acquisition. It is aiming to acquire Vifor Pharma, which is a leader in iron deficiency, nephrology and cardio-renal therapies, for $16.4 billion.
Citi is a fan of CSL. It recently upgraded the company’s shares to a buy rating with a $340.00 price target.
It was pleased with the acquisition of Vifor, commenting: “Because of the large difference in the earnings multiples of both companies and the low cost of debt, we expect the transaction to be double digit NPATA accretive (although ROIC dilutive). The key positive from the transaction is that it expands the CSL late stage R&D pipeline, which we have noted for some time was limited for a company the size of CSL.”
Wesfarmers Ltd (ASX: WES)
Another ASX 200 share to look at is Wesfarmers. It is the conglomerate behind several popular retail brands such as Bunnings and Kmart. It also has a diverse portfolio of industrial businesses.
While FY 2022 has been a tough year because of lockdowns and other COVID headwinds, the company looks well-placed for the future thanks to its strong brands, diverse operations, and balance sheet strength. The latter looks set to support M&A activity and the potential expansion into the healthcare sector.
Morgans is very positive on the company. It currently has an add rating and $60.80 price target on its shares.
The broker recently commented: “The company is run by a highly regarded management team and the balance sheet is healthy. While COVID-related staff shortages are proving to be a challenge, the core Bunnings division (>60% of group EBIT) remains a solid performer as consumers continue to invest in their homes. We see the recent pullback in the share price as a good entry point for longer term investors.”
The post 2 fantastic ASX 200 shares to buy right now appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
*Returns as of January 12th 2022
More reading
- Could this be the biggest issue faced by ASX retail shares heading into earnings season?
- Can the CSL (ASX:CSL) share price crack the $300 mark in 2022?
- Do any ASX lithium shares pay dividends?
- Morgans names 4 more of the best ASX shares to buy in February
- The Wesfarmers (ASX:WES) share price is 20% off its all-time high. Is it a buy?
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia owns and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/PZsw6yp
Leave a Reply